Reviva Pharmaceuticals Holdings,Inc.
|
|
Ioannis Zafirakis
|
|
チーフ・ファイナンシャル・オフィサー、ディレクター
|
|
チーフストラテジーオフィサー、財務局長 兼 秘書
|
|
電話番号:+30-210-9470-100
|
|
メール: m/v Houston の売却完了後
|
|
ウェブサイト: . The Company also expects to take delivery of two methanol dual fuel new-building Kamsarmax dry
bulk vessels by the second half of 2027 and the first half of 2028, respectively. As of today, the co
|
|
X:@ Dianaship
|
|
即時リリース
|
|
投資家及びメディア関係:
|
|
エドワード・ネブ
|
|
Comm-Counsellors, LLC
|
|
電話番号:+ 1-203-972-8350
|
|
メール: The Company desires to take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary
statement in connection with this safe harbor legislation. The words “believe,” “anticipate,” “intends,” “estimate,” “forecast,” “project,” “plan,” “potential,” “may,” “should,” “expect,” “pending” and similar expressions identify forward-looking
statements.
|